《bioRxiv,6月13日,Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-06-14
  • Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4+ T cells

    Benjamin J Meckiff, Ciro Ramirez-Suastegui, Vicente Fajardo, Serena J Chee, Anthony Kusnadi, Hayley Simon, Alba Grifoni, Emanuela Pelosi, Daniela Weiskopf, Alessandro Sette, Ferhat Ay, Gregory Seumois, Christian Ottensmeier, Pandurangan Vijayanand

    doi: https://doi.org/10.1101/2020.06.12.148916

    Abstract

    The contribution of CD4+ T cells to protective or pathogenic immune responses to SARS-CoV-2 infection remains unknown. Here, we present large-scale single-cell transcriptomic analysis of viral antigen-reactive CD4+ T cells from 32 COVID-19 patients. In patients with severe disease compared to mild disease, we found increased proportions of cytotoxic follicular helper (TFH) cells and cytotoxic T helper cells (CD4-CTLs) responding to SARS-CoV-2, and reduced proportion of SARS-CoV-2 reactive regulatory T cells. Importantly, the CD4-CTLs were highly enriched for the expression of transcripts encoding chemokines that are involved in the recruitment of myeloid cells and dendritic cells to the sites of viral infection. Polyfunctional T helper (TH)1 cells and TH17 cell subsets were underrepresented in the repertoire of SARS-CoV-2-reactive CD4+ T cells compared to influenza-reactive CD4+ T cells. Together, our analyses provide so far unprecedented insights into the gene expression patterns of SARS-CoV-2 reactive CD4+ T cells in distinct disease severities.

  • 原文来源:https://www.biorxiv.org/content/10.1101/2020.06.13.149930v1
相关报告
  • 《MICROBES INFECT,3月19日,Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-20
    • Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 YeQiu1Yuan-BoZhao1QiongWangJin-YanLiZhi-JianZhouCe-HengLiaoXing-YiGe Show more https://doi.org/10.1016/j.micinf.2020.03.003 Abstract SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia epidemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2.
  • 《6月13日_湖南大学研究称ACE2的受体利用率表明SARS-CoV-2的宿主范围比SARS-CoV更窄》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-15
    • 1.时间:2020年6月13日 2.机构或团队:湖南大学 3.事件概要: bioRxiv预印平台于6月13日发布了湖南大学的文章“Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV”。 文章指出,受体利用率是决定病毒宿主范围的关键因素,这对于种间传播至关重要。血管紧张素转换酶2(ACE2)是SARS-CoV和SARS-CoV-2的受体,但只有某些动物的ACE2可以被病毒利用。本文中,研究人员使用假病毒细胞进入试验评估了这两种病毒对20种动物的ACE2的受体利用能力,发现SARS-CoV-2所能利用的ACE2比SARS-CoV少,这表明SARS-CoV-2的宿主范围更窄。同时,穿山甲冠状病毒是另一种与SARS-CoV-2基因高度同源的SARS相关冠状病毒,但其与SARS-CoV的ACE2利用图谱更相似,而非SARS-CoV-2。为了阐明受体利用的潜在机制,研究人员比较了20种动物的ACE2的氨基酸序列,发现5个对ACE2利用关键的氨基酸残基,包括可能决定SARS-CoV,SARS-CoV-2和穿山甲CoV不同受体利用的N末端第20和第42个氨基酸。文章表示,其研究促进了对大流行冠状病毒受体利用的了解,可能有助于病原体冠状病毒的病毒追踪、中间宿主筛选和流行病预防。 *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用。 4.附件: 原文链接:https://www.biorxiv.org/content/10.1101/2020.06.13.149930v1